Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Defining the Position of [177Lu]Lu-PSMA Radioligand Therapy in the Treatment Landscape of Metastatic Castration-Resistant Prostate Cancer: A Meta-analysis of Clinical Trials.
Ciccarese C, Bauckneht M, Zagaria L, Fornarini G, Beccia V, Lanfranchi F, Perotti G, Pinterpe G, Migliaccio F, Tortora G, Leccisotti L, Sambuceti G, Giordano A, Caffo O, Iacovelli R. Ciccarese C, et al. Among authors: beccia v. Target Oncol. 2024 Nov 29. doi: 10.1007/s11523-024-01117-1. Online ahead of print. Target Oncol. 2024. PMID: 39613950
Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis.
Mastrantoni L, Chiaravalli M, Spring A, Beccia V, Di Bello A, Bagalà C, Bensi M, Barone D, Trovato G, Caira G, Giordano G, Bria E, Tortora G, Salvatore L. Mastrantoni L, et al. Among authors: beccia v. Lancet Oncol. 2024 Dec;25(12):1655-1665. doi: 10.1016/S1470-2045(24)00511-4. Epub 2024 Nov 11. Lancet Oncol. 2024. PMID: 39542008
2024 ASCO genitourinary cancers symposium: a focus on renal cell carcinoma.
Beccia V, Arduini D, Iacovelli R, Scala A, Occhipinti D, Ligato C, Roca L, Russo P, Foschi N, Tortora G, Ciccarese C. Beccia V, et al. Expert Rev Anticancer Ther. 2024 Aug;24(8):657-660. doi: 10.1080/14737140.2024.2370382. Epub 2024 Jun 27. Expert Rev Anticancer Ther. 2024. PMID: 38912860
Focus on RAS Codon 61 Mutations in Metastatic Colorectal Cancer: A Retrospective Analysis.
Schietroma F, Anghelone A, Valente G, Beccia V, Caira G, Spring A, Trovato G, Di Bello A, Ceccarelli A, Chiofalo L, Perazzo S, Bensi M, Minucci A, Urbani A, Larocca LM, Basso M, Pozzo C, Salvatore L, Calegari MA, Tortora G. Schietroma F, et al. Among authors: beccia v. Cancers (Basel). 2024 Feb 29;16(5):988. doi: 10.3390/cancers16050988. Cancers (Basel). 2024. PMID: 38473349 Free PMC article.
2023 ASCO Genitourinary Cancers Symposium: a focus on urothelial carcinoma.
Cigliola A, Beccia V, Anghelone A, Panebianco M, Ciccarese C, Iacovelli R. Cigliola A, et al. Among authors: beccia v. Expert Rev Anticancer Ther. 2023 Jul-Dec;23(11):1123-1126. doi: 10.1080/14737140.2023.2265570. Epub 2023 Oct 27. Expert Rev Anticancer Ther. 2023. PMID: 37781991
Maintenance strategies after anti-EGFR-based induction in metastatic colorectal cancer: A systematic review and bayesian network meta-analysis.
Mastrantoni L, Beccia V, Caira G, Trovato G, Calegari MA, Basso M, Salvatore L, Pozzo C, Tortora G, Bria E, Orlandi A. Mastrantoni L, et al. Among authors: beccia v. Crit Rev Oncol Hematol. 2023 Nov;191:104106. doi: 10.1016/j.critrevonc.2023.104106. Epub 2023 Sep 1. Crit Rev Oncol Hematol. 2023. PMID: 37659764 Free article. Review.
14 results